madman
Super Moderator
In this third episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine, Drs. Sanacora, Nikayin, and Cristancho discuss the role neuroplasticity may play in the pathogenesis of depression and the benefits to patients of advanced therapies for treatment-resistant depression, such as electroconvulsive therapy and transcranial magnetic stimulation. An overview of emerging evidence for the use of ketamine, esketamine, and psilocybin as new or potential treatments is also examined.
